| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2215/CJN.01660309 |
| P698 | PubMed publication ID | 19423568 |
| P2093 | author name string | Robert N Foley | |
| P433 | issue | 6 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 1136-1139 | |
| P577 | publication date | 2009-05-07 | |
| P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
| P1476 | title | Phosphate levels and cardiovascular disease in the general population | |
| P478 | volume | 4 |
| Q62597853 | A Controlled Increase in Dietary Phosphate Elevates BP in Healthy Human Subjects |
| Q41780200 | Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children |
| Q41971262 | Associations of childhood 25-hydroxyvitamin D2 and D3 and cardiovascular risk factors in adolescence: prospective findings from the Avon Longitudinal Study of Parents and Children |
| Q58781668 | Autophagy Protects From Uremic Vascular Media Calcification |
| Q93005543 | Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats |
| Q64967146 | Cisplatin nephrotoxicity as a model of chronic kidney disease. |
| Q38445037 | Defining, Treating, and Understanding Chronic Kidney Disease--A Complex Disorder |
| Q51240001 | Determinants of phosphorus mobilization during hemodialysis. |
| Q90029481 | Dietary vitamin D interacts with high phosphate-induced cardiac remodeling in rats with normal renal function |
| Q35530311 | Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study |
| Q37522761 | Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study |
| Q84020635 | Efficacy and safety of SBR759, a new iron-based phosphate binder |
| Q38817814 | Elevated serum phosphate levels are associated with decreased amputation-free survival after interventions for critical limb ischemia |
| Q37291894 | FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock |
| Q34244300 | Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort. |
| Q36142874 | High Serum Phosphorus Level Is Associated with Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis Patients |
| Q44470575 | High phosphate directly affects endothelial function by downregulating annexin II. |
| Q61810543 | Higher Intra-Dialysis Serum Phosphorus Reduction Ratio as a Predictor of Mortality in Patients on Long-Term Hemodialysis |
| Q35837789 | Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients |
| Q35668434 | Increased systemic inflammation is associated with cardiac and vascular dysfunction over the first 12 weeks of antiretroviral therapy among undernourished, HIV-infected adults in Southern Africa. |
| Q40974207 | Inorganic Phosphate Activates the AKT/mTORC1 Pathway and Shortens the Life Span of an α‑Klotho-Deficient Model |
| Q50609788 | Interaction of Serum Phosphate with Age as Predictors of Cardiovascular Risk Scores in Stable Renal Transplant Recipients. |
| Q34187537 | Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis |
| Q36191156 | Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters |
| Q88427952 | Low serum phosphate is associated with ischemic stroke in hemodialysis patients |
| Q38765338 | Mineral and bone disorders, morbidity and mortality in end-stage renal failure patients on chronic dialysis |
| Q36890341 | Nutrition in Cardioskeletal Health. |
| Q37231801 | Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism |
| Q55098165 | Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification. |
| Q55027071 | Phosphate excretion is decreased in older cardiac patients with normal kidney function: an emerging dietary risk factor? |
| Q50133293 | Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy |
| Q37492019 | Phosphate: an old bone molecule but new cardiovascular risk factor |
| Q42123269 | Phosphorus metabolism in chronic kidney disease |
| Q51246104 | Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial. |
| Q90102237 | Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters |
| Q50458364 | Sensing of phosphates by using luminescent Eu(III) and Tb(III) complexes: application to the microalgal cell Chlorella vulgaris |
| Q53100607 | Serum phosphorus in people with chronic kidney disease: you are what you eat. |
| Q50188358 | Survival-Related Autophagic Activity Versus Procalcific Death in Cultured Aortic Valve Interstitial Cells Treated With Critical Normophosphatemic-Like Phosphate Concentrations |
| Q37789651 | The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals. |
| Q34027561 | The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation |
| Q27694623 | Treatment of chronic kidney disease |
| Q50764305 | Utility of baseline serum phosphorus levels for predicting remission in acromegaly patients. |
| Q48207375 | Utilizing Dietary Micronutrient Ratios in Nutritional Research May be More Informative than Focusing on Single Nutrients |
Search more.